Trialect

+ More Filters

Reset Filters

Specialty

Funding Organization

Funding Type

Eligible Country

Deadline

From

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Brain Cancer Research-Distinguished Scientist Award

The Sontag Foundation

The Sontag Foundation provides mentorship, direct exposure, and access to a cadre of senior and peer mentors that is unattainable in any other setting.

2025 Application Portal Opens: 1/13/2025

2025 Application Deadline: 3/12/2025 (11:59pm ET)

2025 Funding Awards Announced: Fall 2025

Since 2003, the Sontag Foundation has invested over $65 million dollars to support the scientific careers of young investigators pursing high-risk projects at a critical stage in their research. Interested applicants should carefully read the following information about the award and application process before applying.

Funding

 This award is $750,000; $150,000 per year for a five-year period (*In 2023 the total funding award increased to $750,000 over a five-year period from $600,000 over a four-year period).

 Grant agreements will be issued in October/November of the award year.

 The funding period for 2024 grants will begin on or about October 15, 2024 and end on September 30, 2029.

 Not more than $19,500 may be allocated annually for facilities and administration (F & A) charges or indirect costs. This amount is included in the annual payout of $150,000.

 Disbursements are made on a quarterly basis to the sponsoring institution for use by the award winner and are subject to annual review of his or her progress report.

 During the grant term, grantees are required to attend an annual scientific retreat held in February (all eligible expenses for grantee's travel, lodging, and meals are covered by the Foundation).

Specialties

Cancer

Eligibility Requirements

 Applicants must hold a doctoral degree in a discipline with applicability to brain cancer research.

 Applicants must have received their first independent faculty appointment no earlier than March 1, 2019 and no later than January 1, 2024 at a tax-exempt academic, research, or medical institution within the United States or an equivalent institution in Canada.

 If the institution grants tenure, the qualifying appointment must be on the tenure track.

 Applicant's career track and proposed research should demonstrate outstanding promise as contributors to science relevant to brain cancer research (basic science & related fields encouraged to apply).

 More than one individual from the institution may apply for this award.

 Re-applicants are required to highlight substantive scientific changes from the prior research project, this must include: o Outlining changes in your introduction, summarizing substantial additions, deletions, and changes to the research project; and o Identifying individual changes by using brackets, indents, or change of typography in the text of Specific Aims, Research Approach, and Methods.

 This grant does not support clinical trials research.

 All documents including letters of recommendation and officer approval must be submitted by the application deadline.

Eligible Countries:

Canada

United States

Sponsor Details

Sponsor Institute/Organizations: The Sontag Foundation

Address: 816 A1A North, Suite 201 Ponte Vedra Beach, FL 32082 904-273-8755 / info@sontagfoundation.org

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity

Grant

Final Deadline:

Mar 12, 2025

Funding Amount:

$750,000

Questions and Answers

Commonly asked questions about this funding opportunity from the host and other attendees.

How do I submit an application?

Applications are submitted through the online grant portal. All documents including letters of recommendation and officer approval must be received and uploaded by the deadline to be considered eligible.

The research I propose in this application is my first brain tumor project. May I apply without a background in neuro-oncology research?

Yes. There is great value in bringing other perspectives to bear on the complex questions relating to brain cancer. View the DSA recipients on the website to see the diverse backgrounds and projects of our previous award winners. You will be required to have a mentor with brain cancer experience. A letter of support from your mentor is required. Your mentor letter of support should specifically include information describing your mentor’s experience in brain cancer research, you and your mentor’s relationship, including but not limited to length of relationship, description of role, whether mentor will serve as a collaborator on this project, and mentor’s commitment to your career.

What is the format for the research proposal?

The uploaded document should be formatted with the following dimensions: o Font size should be 11 points or larger. o The type density should be no more than 15 characters per linear inch and the line spacing must be no more than six lines per vertical inch. o We recommend the following fonts: Arial, Georgia, or Helvetica. o Legibility is key for review of your proposal. Applications that do not adhere to the requirement listed above may be withdrawn from consideration

My faculty appointment will become effective soon after the application deadline. May I still apply?

No. If your first faculty appointment was not effective on or before January 1 of the application year, you are considered ineligible, and your application will not be considered.

What should I include in the “Personal Statement?

Tell us about yourself - the Distinguished Scientist Award is best characterized as a career development award. For this reason, the Sontag Foundation is very interested in learning more about you, the applicant. Your statement should share insights beyond information which can be gleaned from your bio sketch and research proposal. Let us know: 1. What is your life story? 2. What caused you to make the career decisions you did? 3. Why did you make the educational choices you did? 4. What people influenced you along the way? Why? 5. What other facts about you and your motivation should we know? Max word count of 1000

How important are the reference letters and who should we ask to provide a letter?

Letters of reference are a key component of your application. Each letter is read thoroughly by every member of the review committee. We are looking for varied insights into you as an individual and your accomplishments at each stage of your career. A reference letter should be solicited from: 1. Department Chair/Program Leader/Center Director, 2. Advisor during Postdoc/Mentor during training, and 3. Professional reference (can be provided by a collaborator, colleague, or mentor) who you feel would be able to share additional insights that would strengthen your application for this grant.